# LAMISIL
> **NDA022071** · New Drug Application · Sponsor: NOVARTIS · Approved 2007-09-28
## Drug
- **FDA Application Number:** NDA022071
- **Application type:** New Drug Application
- **Brand name:** LAMISIL
- **Generic name:** Terbinafine Hydrochloride
- **Active ingredients:** TERBINAFINE HYDROCHLORIDE
- **Dosage form:** GRANULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** NOVARTIS
- **First approval:** 2007-09-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022071)
---
*AI Analytics · CC0 1.0*